318160.KQ Cell Bio Human Tech Co.,Ltd

Consumer Defensive Household & Personal Products KOSDAQ
6,100 KRW
Close of Oct 30, 2026
4,960 11,060
Market cap
KRW 50.0B
P/E
4.8x
P/B
0.82x
ROE
15.8%
Dividend yield
-
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 318160.KQ undervalued?

Graham number
Price6,100
Graham value14,523
Discount58.0%

318160.KQ trades 58.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cell Bio Human Tech Co.,Ltd fundamental analysis

13 of 22 checks passed

ROE 1/2

Moderate return on equity (15.8%), between 10% and 20%.

ROA 1/1

Return on assets (10.5%) is above the industry median (10.1%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (108.7%) is above the industry median (80.3%).

Revenue Growth 2/2

Revenue grew 22.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (20.2%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 8.6x against interest expense, well covered.

PE vs Market 1/1

PE (4.8x) is below the market median (11.3x).

PE vs Industry 1/1

PE (4.8x) is below the industry median (12.4x).

PBV 1/1

Price to book (0.8x) is below the industry median (1.2x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 4.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Cell Bio Human Tech Co.,Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cell Bio Human Tech Co.,Ltd

Cell Bio Human Tech Co.,Ltd develops nonwoven fabric materials for sheet masks in Korea and Vietnam. The company provides sheet masks, patches, skincare products, etc. Its nonwoven fabric materials include PT CELL, a cellulose sheet made from bamboo; SEMI GEL and NC Cell, which are made of lyocell material; and SCell, which is made of rayon material, as well as cotton, microfiber, and PET. The company also offers dried hydrogel sheets and dried biocellulose fabrics. Cell Bio…

Full company profile